This Earmarked Scholarship project is aligned with a recently awarded Category 1 research grant. It offers you the opportunity to work with leading researchers and contribute to large projects of national significance.
Supervisor – Dr Andrea Viecelli, a.viecelli@uq.edu.au
Most patients in the developed world with end-stage kidney disease commence dialysis on a thrice weekly haemodialysis (HD) prescription. There is some evidence this intensive dialysis approach may hasten loss of residual kidney function (RKF), with associated poorer patient outcomes, providing justification to consider starting less frequent, incremental HD (twice weekly) in suitable patients. Incremental dialysis may not only preserve RKF, but provide similar outcomes with a lower dialysis burden and thus be an attractive option for patients, with the additional benefit of cost savings.
INCH-HD is a prospective, multicentre, open label, randomised controlled trial in adults starting HD to determine the efficacy, safety and impacts on quality of life of incremental, twice weekly HD compared to conventional, thrice weekly HD.
Successful candidates will join an established network of post-graduate and early career researchers, who are provided access to support in multidisciplinary research methods, and opportunities for knowledge exchange, networking and collaboration.
Preferred educational background
Applications will be judged on a competitive basis taking into account the applicant's previous academic record, publication record, honours and awards, and employment history.
A working knowledge of nephrology would be of benefit to someone working on this project.
The applicant will demonstrate academic achievement in the field(s) of health sciences and the potential for scholastic success.
Preference is for the candidate to be co-located with the Australasian Kidney Trials Network in Brisbane, but consideration will be given to candidates requiring to be located off-site such as in other states.
*The successful candidate must commence by Research Quarter 1, 2024. You should apply at least 3 months prior to the research quarter commencement date. International applicants may need to apply much earlier for visa reasons.